Trials / Not Yet Recruiting
Not Yet RecruitingNCT07339995
Fertility Outcomes of Ovarian Tissue Cryopreservation
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Chinese University of Hong Kong · Academic / Other
- Sex
- Female
- Age
- 0 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
With the advancement of assisted reproductive technology, more young cancer patients can consider having children. Ovaries and testes are important reproductive organs, and drugs, diseases, chemotherapy, and radiotherapy can all damage them. Reproductive preservation technology aims to protect patients whose reproductive ability has been damaged due to gonadotoxic drug therapy. Women can preserve their reproductive ability by freezing ovarian tissue cryopreservation so that they can have children in the future. Patients who have undergone or will undergo ovarian tissue cryopreservation in Hong Kong Children's Hospital will be invited to participate in the study. Here, we aim to evaluate the outcomes after ovarian tissue cryopreservation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Ovarian tissue freezing and subsequent auto-transplantation after thawing | Removal of the ovarian tissue will be retrieved via laparoscopic surgery under general anesthesia. The ovarian cortical tissue obtained will be transferred on ice to the laboratory for cryopreservation. After medical treatment, if the patient would like to start a family but has experienced premature ovarian failure, she will have ovarian tissue auto-transplantation after thawing. |
Timeline
- Start date
- 2026-01-15
- Primary completion
- 2031-01-14
- Completion
- 2032-01-14
- First posted
- 2026-01-14
- Last updated
- 2026-01-14
Source: ClinicalTrials.gov record NCT07339995. Inclusion in this directory is not an endorsement.